Brain inflammation co-localizes highly with tau in mild cognitive impairment due to early-onset Alzheimer’s disease

Brain inflammation, with an increased density of microglia and macrophages, is an important component of Alzheimer’s disease and a potential therapeutic target. However, it is incompletely characterized, particularly in patients whose disease begins before the age of 65 years and, thus, have few …